Stockreport

Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are [Read more]